Estimation of StilbostatR treatment efficiency in breast cancer by thermography.
Administration of Stilbostat to postmenopasual women with advanced breast cancer markedly improved the clinical state in about 65% of the cases and concomitantly decreased the cutaneous thermic values at the level of the lesions showing a tendency to equalize the values recorded for the symmetrical healthy cutaneous zones. The thermographic test is proposed as a means of estimating the Stilbostat treatment efficiency in breast cancer.
D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D004054:Diethylstilbestrol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D013817:Thermography
D009588:Nitrogen Mustard Compounds; C009323:stilbostat; D004054:Diethylstilbestrol